ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,790Medicare Part D Prescriptions Filled, Including Refills

Rank: 401 out of 2429

$474K Total Retail Price of All Prescriptions

Rank: 312 out of 2429

456 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

13% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,446 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 286 270 1 3
LISINOPRIL 278 264 2 2
FUROSEMIDE 251 246 3 5
SIMVASTATIN 246 226 4 1
NAMENDA 233 233 5 35
WARFARIN SODIUM 226 218 6 11
OMEPRAZOLE 193 191 7 7
CITALOPRAM HBR 166 164 8 19
HYDROCODONE-ACETAMINOPHEN 166 140 S3 8 6
DONEPEZIL HCL 158 158 10 26
HYDROCHLOROTHIAZIDE 154 146 11 10
AMLODIPINE BESYLATE 147 144 12 4
METOPROLOL SUCCINATE 133 129 13 12
PRAVASTATIN SODIUM 129 124 14 16
METOPROLOL TARTRATE 122 113 15 9
SERTRALINE HCL 116 116 16 23
ATORVASTATIN CALCIUM 115 111 17 13
ALENDRONATE SODIUM 107 107 18 20
KLOR-CON M20 105 104 19 60
FENTANYL 102 95 S2 20 59
METFORMIN HCL 97 84 21 8
ATENOLOL 94 88 22 15
POTASSIUM CHLORIDE 94 89 22 14
CARVEDILOL 90 87 24 21
MIRTAZAPINE 87 87 25 63
PANTOPRAZOLE SODIUM 83 78 26 34
FAMOTIDINE 81 81 27 42
GABAPENTIN 80 80 28 18
SPIRONOLACTONE 69 69 29 62
CYMBALTA 65 61 30 58
PREDNISONE 64 60 31 38
ZOLPIDEM TARTRATE 64 64 31 28
QUETIAPINE FUMARATE 61 61 33 77
CRESTOR 59 59 34 25
POLYETHYLENE GLYCOL 3350 58 58 35 56
DILTIAZEM 24HR CD 56 51 36 94
TAMSULOSIN HCL 56 56 36 29
ALLOPURINOL 55 51 38 33
DIOVAN 52 52 39 36
ENALAPRIL MALEATE 51 51 40 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.